Microbiotaevents for Healthcare Professionals

Effects of B. longum 35624 on disease severity and quality of life.

icon calendrier Wednesday, 14th December 2022
time 4:00pm - 4:30pm (CET)
Join the Microbiota Events Community
COMMUNITY

A global community gathering healthcare professionals to discover the latest developments in the microbiota sphere. 

LIVE EVENTS

Gain exclusive access to a slate of virtual events, engaging sessions in which our panel of experts present cutting-edge research and innovations.

EXPERTS

From leading institutions, our lineup of world-class experts and key opinion leaders share their ideas, knowledge and expertise on a number of pertinent topics related to microbiota realm.

RESOURCES

Relevant content from each event is available to our community: on-demand replay of live events and downloadable documents including digests, presentations, studies, and expert interviews. 

Join the Microbiota Events Community
COMMUNITY

A global community gathering healthcare professionals to discover the latest developments in the microbiota sphere. 

LIVE EVENTS

Gain exclusive access to a slate of virtual events, engaging sessions in which our panel of experts present cutting-edge research and innovations.

EXPERTS

From leading institutions, our lineup of world-class experts and key opinion leaders share their ideas, knowledge and expertise on a number of pertinent topics related to microbiota realm.

RESOURCES

Relevant content from each event is available to our community: on-demand replay of live events and downloadable documents including digests, presentations, studies, and expert interviews. 

Speakers

Meet our world-class panel of experts in the microbiota field appearing in our events.
  • Jorge Amil Dias
    Dr. Jorge Amil Dias

    MD, Pediatric Gastroenterology, Hospital Lusíadas (Porto, Portugal)

  • Dr Arrieta
    Dr. Marie-Claire Arrieta

    Assistant Professor in the departments of Physiology, Pharmacology and Pediatrics of the University of Calgary, (Calgary, Canada).

  • Professor Martin Jack Blaser
    Prof. Martin J. Blaser

    Director of the Center for Advanced Biotechnology and Medicine and Professor of medicine in universities (New Jersey, USA)

  • Roberto Berni Canani
    Prof. Roberto Canani

    MD PhD, Professor of Pediatrics and specialist in pediatric gastroenterology, food allergy and nutrition, University Federico II (Naples, Italy)

  • Professor Henry Cohen
    Prof. Henry Cohen

    Professor and chairman of gastroenterology, Hospital de Clínicas (Montevideo, Uruguay)

  • Dr Maura Corsetti
    Dr. Maura Corsetti

    MD, PhD, Clinical Associate Professor in Gastroenterology at the University of Nottingham, Translational Medical Sciences; Nottingham Digestive Disease Biomedical Research Centre (Nottingham, UK)

  • Prof Dinleyici
    Prof. Ener Cagri Dinleyici

    Professor of Pediatrics at the Eskisehir Osmangazi University Faculty of Medicine, (Eskisehir, Turkey).

  • Joël Doré
    Dr. Joël Doré

    PhD, Scientific Director of the MetaGenoPolis, Center of Excellence in Microbiome Analysis (Paris, France)

  • The impact of Saccharomyces boulardii CNCM I-745 in gastrointestinal immune responses¹

    "Our understanding of immunity has improved considerably during the last decades, due to the discovery and description of a set of specialized structure for the induction of cellular and humoral immunity: the mucosa-associated tissues also called MALT. In human, these structures are present in the upper respiratory tract (nose and pharynx) but the vast majority of them are housed in the gut which is the largest interface between the external envrionment and the internal milieu."

    Professeur Francisco Guarner
    Prof. Francisco Guarner

    Consultant of gastroenterology, Centro Médico Teknon (Barcelona, Spain)

    01 . Guarner et al. Probiotics and prebiotics. World Gastroenterology Organisation Global Guidelines. February 2017. https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english. Last accessed 13th December 2019

    Discover a unique probiotic yeast:
    Discover a unique probiotic yeast:
    S. boulardii CNCM I-745
    S. boulardii CNCM I-745
    macbook

    Since its discovery, Saccharomyces boulardii CNCM I-745 has been used for over 56 years to treat more than 460 million people (and counting!)
    A unique, singe strain yeast probiotic deserved to get its own website!

    biocodex
    biocodex
    The Biocodex Microbiota Institute is an international knowledge hub that aims to foster better health by spreading knowledge about human microbiota.
    About us
    Biocodex is a family-owned pharmaceutical company that has grown from a French microbiota pioneer in the 1950s to an international pharmaceutical player today by diversifying its products and expanding its geographical footprint. We offer health solutions to patients in more than 120 countries through our own operations or long-term partnerships. We are proud of our teams, who are united by shared values. These serve as driving forces, enabling us to grow while remaining agile.